← Back to headlines
United Therapeutics Targets $4 Billion Revenue Run Rate by 2027
United Therapeutics outlined plans to achieve a $4 billion revenue run rate by the end of 2027, driven by advancements in its ralinepag and IPF programs.
6 May, 18:12 — 6 May, 18:12
Sources
Showing 1 of 1 sources
